KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,620,550 | -21.9% | 323,578 | -36.7% | 0.01% | -20.0% |
| Q2 2023 | $7,195,190 | +64.0% | 511,022 | +25.3% | 0.02% | +50.0% |
| Q1 2023 | $4,387,519 | +102.0% | 407,762 | +181.2% | 0.01% | +100.0% |
| Q4 2022 | $2,172,325 | +698.6% | 145,015 | +842.3% | 0.01% | – |
| Q4 2020 | $272,000 | -2.9% | 15,390 | -15.7% | 0.00% | – |
| Q3 2020 | $280,000 | -2.1% | 18,258 | +62.4% | 0.00% | – |
| Q2 2020 | $286,000 | – | 11,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |